162 / 220
1 5 8
NOTES TO THE FINANCIAL STATEMENTS
31 MARCH 2018
fInanCIal StatementS
15. Biological assets
Group
2018
2017
RM’000
RM’000
Cost
At 1 April 2017/2016
240,693
204,016
Additions
18,690
30,228
Acquisition of subsidiary
8,600
-
Write off
-
(115)
Exchange differences
(9,495)
6,564
At 31 March
258,488
240,693
Accumulated amortisation and impairment loss
At 1 April 2017/2016
84,485
50,540
Charge for the year:
- Amortisation
3,893
6,450
- Impairment loss
-
24,779
Write off
-
(45)
Exchange differences
(7,684)
2,761
At 31 March
80,694
84,485
Analysed as:
Accumulated amortisation
55,915
59,706
Accumulated impairment loss
24,779
24,779
80,694
84,485
Net carrying amount
At 31 March
177,794
156,208